Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT02012140
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- LifeBridge Health
- Registry
-
NCT02012140
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- Not reported
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT02012140. Non-randomized; no masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2015-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI
- Condition
- Cardiovascular Disease
- Condition
- Stable Angina
- Condition
- Myocardial Infarction
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- ticagrelor
- Lead sponsor
- LifeBridge Health
Record details
- Record id
cardio:ct-nct02012140- Content hash
71434b8bdfb8cf69a2face7b989b60ea7987ebac9057838eabf66319e40cb79d